申请人:Japan Tobacco Inc.
公开号:EP3760624A1
公开(公告)日:2021-01-06
An object of the present invention is to provide a methyllactam ring compound that has an SGLT1 inhibitory activity and is useful for a drug, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising it, and pharmaceutical use thereof. A compound of Formula [I]:
or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising it, and pharmaceutical use thereof is provided.
本发明的目的是提供一种具有SGLT1抑制活性并可用于药物的甲基内酰胺环化合物或其药学上可接受的盐、由其组成的药物组合物及其药物用途。一种式[I]化合物:
或其药学上可接受的盐、包含它的药物组合物及其药物用途。